What's breaking now, across thousands of outlets.
Animal health companies are tapping into the protein craze, investing billions of dollars to build up businesses focused on making cattle, pigs and poultry healthier for human consumption.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
At Holdings Channel, we have reviewed the latest batch of the 59 most recent 13F filings for the 09/30/2026 reporting period, and noticed that BRK (Symbol: BRK) was held by 32 of these funds.
Investors don't see Marvell's new acquisition as being so marvelous.
Key PointsBristol Myers Squibb is an established pharmaceutical powerhouse with a high-yield dividend and a focus on expanding its portfolio through strategic oncology alliances.
Claiming at 62 means accepting a permanent reduction in monthly income, but it unlocks years of immediate cash flow.